Effect of chain length and branching on the in vitro metabolism of a series of parabens in human liver S9, human skin S9, and human plasma.
暂无分享,去创建一个
C. Obringer | J. Troutman | Shengde Wu | C. Lester | M. Karb
[1] Ligong Lu,et al. Occurrence of parabens and their metabolites in the paired urine and blood samples from Chinese university students: Implications on human exposure. , 2020, Environmental research.
[2] M. Ferrer,et al. Organic-Solvent-Tolerant Carboxylic Ester Hydrolases for Organic Synthesis , 2020, Applied and Environmental Microbiology.
[3] H. Maibach,et al. Skin Metabolism: Relevance of Skin Enzymes for Rational Drug Design , 2019, Skin Pharmacology and Physiology.
[4] E. Warshaw,et al. Parabens: Contact (Non)Allergen of the Year. , 2018, Dermatitis : contact, atopic, occupational, drug.
[5] Li Di,et al. The Impact of Carboxylesterases in Drug Metabolism and Pharmacokinetics , 2018, Current drug metabolism.
[6] Guangbo Ge,et al. Recent progress in the discovery of natural inhibitors against human carboxylesterases. , 2017, Fitoterapia.
[7] R. Upton,et al. Food, gastrointestinal pH, and models of oral drug absorption , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[8] T. Brüning,et al. Metabolism and elimination of methyl, iso- and n-butyl paraben in human urine after single oral dosage , 2016, Archives of Toxicology.
[9] S. Kitamura,et al. Comparative study of the hydrolytic metabolism of methyl-, ethyl-, propyl-, butyl-, heptyl- and dodecylparaben by microsomes of various rat and human tissues , 2013, Xenobiotica; the fate of foreign compounds in biological systems.
[10] V. Herring,et al. The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance? , 2013, Pharmacotherapy.
[11] M. Ross,et al. Examination of the carboxylesterase phenotype in human liver. , 2012, Archives of biochemistry and biophysics.
[12] T. Ameller,et al. Systemic exposure to parabens: pharmacokinetics, tissue distribution, excretion balance and plasma metabolites of [14C]-methyl-, propyl- and butylparaben in rats after oral, topical or subcutaneous administration. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[13] U. Hass,et al. Possible endocrine disrupting effects of parabens and their metabolites. , 2010, Reproductive toxicology.
[14] F. Williams,et al. Hydrolysis of a series of parabens by skin microsomes and cytosol from human and minipigs and in whole skin in short-term culture. , 2007, Toxicology and applied pharmacology.
[15] Teruko Imai,et al. Carboxylesterase in the liver and small intestine of experimental animals and human. , 2007, Life sciences.
[16] P. Potter,et al. Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. , 2007, Toxicology and applied pharmacology.
[17] Teruko Imai,et al. Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small Intestine , 2006, Drug Metabolism and Disposition.
[18] L. Di,et al. High throughput microsomal stability assay for insoluble compounds. , 2006, International journal of pharmaceutics.
[19] R. Voorman,et al. Comparison of Skin Esterase Activities from Different Species , 2006, Pharmaceutical Research.
[20] B. Forbes,et al. Transesterification of p-hydroxybenzoate esters (parabens) by human intestinal (Caco-2) cells , 2006, Xenobiotica; the fate of foreign compounds in biological systems.
[21] E. Duysen,et al. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. , 2005, Biochemical pharmacology.
[22] M. Soni,et al. Safety assessment of esters of p-hydroxybenzoic acid (parabens). , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[23] R Scott Obach,et al. Drug metabolism and drug interactions: application and clinical value of in vitro models. , 2003, Current drug metabolism.
[24] N. Bodor,et al. Quantitative structure-metabolism relationships: steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters. , 1999, Journal of medicinal chemistry.
[25] J. Magdalou,et al. Metabolism of parabens (4-hydroxybenzoic acid esters) by hepatic esterases and UDP-glucuronosyltransferases in man. , 2010, Drug metabolism and pharmacokinetics.
[26] H. Harville,et al. Comparison of paraben stability in human and rat skin. , 2007, Drug metabolism letters.
[27] S. Ishiwatari,et al. Effects of methyl paraben on skin keratinocytes , 2007, Journal of applied toxicology : JAT.
[28] Teruko Imai,et al. Human carboxylesterase isozymes: catalytic properties and rational drug design. , 2006, Drug metabolism and pharmacokinetics.